Literature DB >> 11754191

Neurogenic involvement in a case of oculopharyngeal muscular dystrophy.

Yassine Boukriche1, Thierry Maisonobe, Catherine Masson.   

Abstract

We report the case of a 65-year-old man with a 15-year history of oculopharyngeal muscular dystrophy (OPMD) harboring a (GCG)11 mutation of the poly(A)-binding protein 2 (PABP2) gene. He developed, early in the course of the disease, a severe chronic axonal neuropathy. Although the primary myopathic origin of the disease appears to be established, a small number of cases of OPMD with neuropathic features have been described. This case raises the question of a possible neurogenic component to this disease and the role of the length of the mutation in phenotype severity. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754191     DOI: 10.1002/mus.1213

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Unique PABPN1 gene mutation in a large Bulgarian family with OPMD.

Authors:  V Mihaylova; T Müller; I Petrova; I Tournev; S Cherninkova; M C Walter; M Deschauer
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

Review 2.  PABPN1: molecular function and muscle disease.

Authors:  Ayan Banerjee; Luciano H Apponi; Grace K Pavlath; Anita H Corbett
Journal:  FEBS J       Date:  2013-05-24       Impact factor: 5.542

3.  Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.

Authors:  A Abu-Baker; J Laganiere; R Gaudet; D Rochefort; B Brais; C Neri; P A Dion; G A Rouleau
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

Review 4.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.